Navigation Links
InfoSpi Shall Benefit From Contract for Future Use of IBS Technology
Date:2/5/2010

FT. LAUDERDALE, Fla., Feb. 5 /PRNewswire-FirstCall/ -- InfoSpi Inc. (OTC Bulletin Board: ISPI) announced today an important development within the process of the negotiations to acquire the business and advanced technology of Integral Bioenergies Systems, SL (IBS). This firm has developed and protected a proprietary technology process that allows the treatment of biomass/sludge obtained at sewage treatment plants.

IBS has entered into a contract with Tedagua (www.tedagua.com), a member of the ACS Group (www.acscorporate.com). Tedagua is a worldwide leader in the industry of water treatment plants operating projects in many cities of Mexico, Central and South America, Africa, China and the Middle East.

Onildo Mersing Huusmann, President and CEO of IBS, said, "This contract will allow the future use of IBS's technology in the processing and treatment of biomass/sludge obtained at sewage/water-treatment plants."

Chris Hamilton, CEO of InfoSpi states that this contract shall afford a great opportunity for InfoSpi in the development of its plans.

Safe Harbor Statement

This press release contains statements that may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of InfoSpi Inc. and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully, and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

www.infospiinc.com

SOURCE InfoSpi Inc.

RELATED LINKS
http://www.infospiinc.com

'/>"/>

SOURCE InfoSpi Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. InfoSpi to Create $500m Green Hedge Fund Focusing on the Carbon Credit Market
2. Isis Announces Appointment of B. Lynne Parshall as Chief Operating Officer
3. John Marshall and Kevin McGuinness Appointed to Ellex Board
4. Marshall Edwards, Inc. to Present at BIO Investor Forum 2007
5. Adaptive Trial Paper Explores Benefits of Adaptive Trials for Phase I, Phase II Studies
6. Æterna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Perifosine (KRX-0401) in the Treatment of Advanced Metastatic Colon Cancer
7. Global Regulators to Discuss Benefit-Risk Approaches of Medicinal Products at DIA Workshop
8. Commercial Insurance Buyers Benefit From Ample Capacity
9. TriLink BioTechnologies to Sponsor GIVING HUNGER THE BLUES, a Benefit Concert to Help Alleviate Hunger in San Diego County
10. OncoGenex Pharmaceuticals Completes Amendment to Phase 3 Special Protocol Assessment for Confirming Survival Benefit in Patients Receiving OGX-011 with First-Line Docetaxel for Metastatic Prostate Cancer
11. LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Diego, CA (PRWEB) , ... April 20, 2017 , ... ... management of clinical trials worldwide, announced today that they were named one of the ... , which covers the latest developments in the pharmaceutical industry. , “We take pride ...
(Date:4/19/2017)... ... 18, 2017 , ... The Vibrating Orifice Aerosol Generator (VOAG) ... monodisperse droplets of known diameters for research applications such as for calibrating droplet ... drying monodisperse droplets. , The VOAG requires forcing liquid out of an ...
(Date:4/19/2017)... ... April 19, 2017 , ... ThermaGenix, the PCR Improvement Company, ... to several other early achievements at ThermaGenix, including the business formation and licensing ... ThermaGenix will use proceeds from the Series A-1 round to:, ...
(Date:4/19/2017)... and WESTMINSTER, Colo. , April ... an industry-leading specialty finance firm that provides senior ... today announced the closing of a $20 million ... a privately-held orthobiologics company engaged in the development ... the treatment of orthopedic injuries. Cerapedics, ...
Breaking Biology Technology:
(Date:4/18/2017)... -- Socionext Inc., a global expert in SoC-based imaging and computing solutions, ... which features the company,s hybrid codec technology. A demonstration utilizing TeraFaces ... will be showcased during the upcoming Medtec Japan at Tokyo Big ... Las Vegas Convention Center April 24-27. ... Click here for an image of ...
(Date:4/13/2017)... SANTA MONICA, Calif. , April 13, 2017 /PRNewswire/ ... New York will feature emerging and ... Innovation Summits. Both Innovation Summits will run alongside the ... variety of speaker sessions, panels and demonstrations focused on ... east coast,s largest advanced design and manufacturing event will ...
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
Breaking Biology News(10 mins):